blog
Blog
How Improving Diversity Can Benefit Clinical Trials
Representation and inclusion of various minority groups is crucial for medical research. Discover how drug developers, researchers, and regulators are ensuring this happens.
Blog
Top 10 Life Science Resources for Summer 2024
Discover 10 more essential life science resources, including expert insights, tips, case studies, webinars, podcasts, posters, scientific publications, videos, and more, that you may have missed from us!
Blog
Optimizing for Success: How Sponsors Can Overcome the Challenges in Early-Phase Drug Development
Early-phase drug development is a complex process. Discover how Altasciences, as an integrated CRO/CDMO, alleviates the challenges and reduces risks.
Blog
Five Promising Treatment Areas in Early-Phase Drug Development in 2024
Explore emerging areas of drugs from psychedelics and gene therapy, oligonucleotides to GLP-1RA for metabolic disorders.
Blog
Disrupting the CRO Model: Altasciences Participates in Documentary Series for 2024 Global Health Summit
Can the drug development industry change for the better? We dive into the obstacles and inefficiencies of the traditional outsourcing paradigm, and discuss how Altasciences offers an alternative to help sponsors safely accelerate their R&D.
Blog
Healing Hearts: A Journey of Compassion and Commitment
Discover the inspiring journey of Altasciences’ Marta Rodriguez, Director of Clinical and Study Operations, who decided to pursue science after her parents fell ill.
Blog
Webinar: Assessing Cognition Impairment Using Driving Simulators in Clinical Trials
Learn more about how Altasciences can test cognition, and the impact of driving under the influence of medication, using our state-of-the-art driving simulators.